Our findings also imply a novel inter-organ network between kidney and PRAT, possibly mediated by leptin, for the development of DN, and thus suggests new clinical implications for the prevention and treatment of DN through pharmacological intervention. The gene discussed is LEP; the disease is liver dysplastic nodule.